Detalhe da pesquisa
1.
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.
Cell
; 185(7): 1208-1222.e21, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305314
2.
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.
PLoS Pathog
; 17(2): e1009165, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571304
3.
ß2-adrenergic signaling promotes higher-affinity B cells and antibodies.
Brain Behav Immun
; 113: 66-82, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369341
4.
Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens.
iScience
; 26(2): 105957, 2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36687315
5.
Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics.
JCI Insight
; 8(13)2023 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37252802
6.
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.
Commun Biol
; 5(1): 789, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931732
7.
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases.
Vaccines (Basel)
; 10(8)2022 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35893835
8.
Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis.
Nat Commun
; 12(1): 602, 2021 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504803
9.
Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors.
bioRxiv
; 2020 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33052341